Who are BiomeSense's investors?

BiomeSense's investors include Bluestein & Associates, BioX Clan, Emil Capital, Labcorp, SOSV.

When was BiomeSense founded?

BiomeSense was founded in 2018.

Where is BiomeSense headquartered?

BiomeSense is headquartered in Chicago, Illinois, United States.

What industry is BiomeSense in?

BiomeSense operates in Biotech, Healthcare.

How many employees does BiomeSense have?

BiomeSense has 11-50 employees.

BiomeSense

Leveraging the power of big data & AI to unlock microbiome precision medicine.

Chicago, United States · Founded 2018

Biotech

Healthcare

Headquarters: Chicago, Illinois
Employees: 11–50
Founded: 2018
Business Model: B2C

Website: biomesenseinc.com
Last Round: Venture RoundOct 2025
Rounds: 5

About

BiomeSense develops AI-enabled technology platforms for continuous gut microbiome tracking and precision medicine. Their GutLab device enables at-home longitudinal sample collection, while the MetaBiome AI platform analyzes microbiome data to identify clinically relevant patterns for biomarker discovery and therapeutic development.

Summary

BiomeSense is a Biotech company based in Chicago, United States, founded in 2018. Its most recent funding was a Venture Round round in Oct 2025. Investors include Bluestein & Associates, BioX Clan and Emil Capital.

LinkedIn X (Twitter)